Elekta AB (publ) (OTCMKTS:EKTAY) Sets New 1-Year Low – Here’s Why

Elekta AB (publ) (OTCMKTS:EKTAY) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $5.57 and last traded at $5.58, with a volume of 19699 shares traded. The stock had previously closed at $5.72.

Elekta AB (publ) Price Performance

The firm has a market capitalization of $2.17 billion, a P/E ratio of 20.18 and a beta of 1.23. The business’s 50-day simple moving average is $6.38 and its 200 day simple moving average is $6.57. The company has a quick ratio of 0.74, a current ratio of 0.99 and a debt-to-equity ratio of 0.45.

Elekta AB (publ) (OTCMKTS:EKTAY) last released its earnings results on Wednesday, August 28th. The company reported $0.04 EPS for the quarter. Elekta AB (publ) had a net margin of 6.25% and a return on equity of 12.23%. The company had revenue of $359.76 million for the quarter. Sell-side analysts forecast that Elekta AB will post 0.41 earnings per share for the current year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.